NCT00678886 · Interventional trial
Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus, Type 1
Delaware Valley sites
- GSK Investigational Site · Langhorne, PA · Bucks County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory